Curanex Pharmaceuticals Inc Common Stock financial statements
큐러넥스 파머슈티컬스NASDAQ:CURX · Nasdaq$4.99+0.60%
2026-10-06 close · prelimCuranex Pharmaceuticals Inc Common Stock's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was $0M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy